Add BrightSurf on Google Email

Once-a-day epilepsy drug is effective for partial seizures

A new once-daily lamotrigine extended-release formula effectively controls partial seizures in people already taking one to two medications. The study found significant reductions in seizure frequency and improved medication adherence, making it a promising option for those with epilepsy.

SourceAmerican Academy of Neurology·JournalNeurology·DateOct 15, 2007
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Miniature implanted devices could treat epilepsy, glaucoma

Researchers at Purdue University developed miniature devices to predict and prevent epileptic seizures by detecting neural signals in the brain. The system records data from 1,000 channels, enabling better prediction of seizure onset. A nanotech sensor for glaucoma treatment is also being developed.

SourcePurdue University·DateAug 7, 2007
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Next-generation neurotechnology possible with NIH grant

The innovative university-industry team will develop a microsystem-on-a-chip, a neural interface that records or stimulates neural activity wirelessly. The new system will be fully implantable and communicate through digital data streaming, allowing people with paralysis to control assistive devices.

SourceBrown University·DateAug 2, 2007

OVATION expands drug development pipeline

A clinical trial is underway to assess the safety and efficacy of intravenous carbamazepine in adult patients with epilepsy. The new treatment aims to provide an alternative to oral therapy during hospitalization or when oral administration is not feasible.

SourceEdelman Public Relations, New York·DateJul 31, 2007
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

The future of medicine -- Insert chip, cure disease?

University of Florida researchers are creating a brain chip to decode signals and stimulate neurons, aiming to treat conditions like paralysis and epilepsy. The technology has the potential to revolutionize medicine, allowing patients to control prosthetic devices with their thoughts.

SourceUniversity of Florida·JournalJournal of Neuroscience Methods·DateJul 25, 2007

Evidence found for novel brain cell communication

Scientists found evidence of a new type of communication between nerve cells in the brain, which may be linked to epilepsy. The discovery suggests that excitatory nerve cells are coupled together by gap junctions, potentially leading to cross-talk and altered brain function.

SourceSUNY Downstate Health Science University·JournalProceedings of the National Academy of Sciences·DateJul 16, 2007

Epilepsy means 3 times higher risk of committing suicide

A study published in The Lancet Neurology found that people with epilepsy are three times more likely to commit suicide than the general population. Women with epilepsy face an increased risk, as do those diagnosed with the condition in the previous six months.

SourceThe Lancet_DELETED·JournalThe Lancet Neurology·DateJul 2, 2007

How brain pacemakers erase diseased messages

Biomedical engineers at Duke University found that deep brain stimulation alleviates disease symptoms by creating an informational lesion through rapid-fire electrical pulses. This technique can be reversible and adjustable, offering a promising treatment for movement disorders and other conditions.

SourceDuke University·JournalIEEE Transactions on Neural Systems and Rehabilitation Engineering·DateMay 30, 2007
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

SUMO wrestling in the brain

Increasing SUMO levels could help treat diseases like epilepsy by reducing over-excitation in brain cells. The discovery provides new insights into the causes of brain disorders and potential targets for drug development.

SourceUniversity of Bristol·JournalNature·DateMay 7, 2007

Lower IQ found in children of women who took epilepsy drug

A study of 187 two-year-old children found that those whose mothers took valproate during pregnancy had a higher risk of lower IQ. Children exposed to valproate showed an IQ in the mental retardation range at a rate of 24%, compared to 12% for carbamazepine and phenytoin, and 9% for lamotrigine.

SourceAmerican Academy of Neurology·DateMay 3, 2007

Anti-dandruff compound may help fight epilepsy

Researchers at Johns Hopkins have discovered that zinc pyrithione, an active ingredient in dandruff shampoos, can calm overexcited nerve cells, potentially treating seizures. The compound works by allowing more potassium flow through defective channels, restoring normal nerve cell activity.

SourceJohns Hopkins Medicine·JournalNature Chemical Biology·DateApr 27, 2007
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

New genes identified in childhood fever-related seizures

Researchers have localized two new genes associated with febrile seizures in infancy and childhood, which could improve the understanding, treatment, and prevention of this disorder. The study found that chromosome 3 was shared by all family members who had febrile seizures, while a modifier gene on chromosome 18 may also be involved.

SourceAmerican Academy of Neurology·JournalNeurology·DateApr 23, 2007

Epilepsy drug with new method of action is safe, effective

A study published in Neurology found that retigabine, a new epilepsy drug with a unique mechanism of action, is both safe and effective. In the study, participants who received the highest dose of retigabine experienced an average reduction of 35% in seizure frequency compared to those receiving a placebo.

SourceAmerican Academy of Neurology·JournalNeurology·DateApr 9, 2007

MIT: Pulsing light silences overactive neurons

Scientists at MIT have developed a way to reversibly silence brain cells using pulses of yellow light, potentially leading to the development of optical brain prosthetics. The method could enable specific treatments with few or no side effects, offering new hope for neurological and psychiatric diseases.

SourceMassachusetts Institute of Technology·JournalPLOS ONE·DateMar 27, 2007

Sunny days pose risk of 'flicker illness' for a few airlifted patients

A case report suggests that light streaming through whirling helicopter rotor blades during medical air transport can cause symptoms ranging from nausea to full-blown seizures. Researchers recommend shielding patients' eyes to prevent this under-recognized but highly preventable complication.

SourceUniversity of Rochester Medical Center·JournalPrehospital Emergency Care·DateMar 5, 2007
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Does tooth-brushing cause epilepsy seizures?

Researchers found that tooth-brushing can induce seizures in individuals with epilepsy, possibly linked to lesions in the somatosensory area of the brain. The study suggests a potential link between rhythmic stimuli and seizure activity.

SourceAmerican Academy of Neurology·JournalNeurology·DateMar 5, 2007

Rare cell prevents rampant brain activity

Scientists at Karolinska Institutet have discovered a mechanism controlling how the brain maintains equilibrium in neuronal activity. A rare cell type, Martinotti cell, acts as a safety device by sending inhibitory signals to surrounding pyramid cells when activated excessively.

SourceKarolinska Institutet·JournalNeuron·DateMar 2, 2007

No more seizures? New drug holds promise for epilepsy patients

A clinical trial found that nearly 600 adults with newly diagnosed epilepsy experienced few to no seizures while taking levetiracetam as a single therapy. The study also showed that patients remained seizure-free for at least six months at the lowest dose level.

SourceAmerican Academy of Neurology·JournalNeurology·DateFeb 5, 2007
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Can epilepsy patients predict their seizures?

Researchers found that epilepsy patients can reliably predict when they are likely to have a seizure, with 32% accuracy. Accurate predictions also indicate reduced risk of seizures, providing reassurance and improved quality of life for those with epilepsy.

SourceAmerican Academy of Neurology·JournalNeurology·DateJan 22, 2007

New neurons could act to alleviate epilepsy

Researchers found that new neurons generated in response to epilepsy have reduced excitability and increased inhibitory connectivity, potentially alleviating the disorder. These findings suggest that therapies aimed at inducing neurogenesis could prove effective.

SourceCell Press·JournalNeuron·DateDec 20, 2006

Commonplace sugar compound silences seizures

Researchers at UW-Madison discover 2-deoxy-glucose blocks epileptic seizures in lab rats, a potential cure for up to half of all epileptic patients. The compound works by clogging cellular enzymes, allowing the body to use alternative energy sources.

SourceUniversity of Wisconsin-Madison·JournalNature Neuroscience·DateOct 15, 2006
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

MIT device could prevent epileptic seizures

Researchers at MIT are developing a device that can detect and prevent epileptic seizures by measuring brain activity. The new technology builds on an existing therapy and could be refined to work with a headband or baseball cap. If successful, it would allow more patients to use the therapy on demand.

SourceMassachusetts Institute of Technology·JournalEpilepsy & Behavior·DateSep 12, 2006

Epilepsy medication proving ineffective over time

A critical review found that repeated administration of antiepileptic drug therapy leads to diminishing results in preventing seizures. Acquired tolerance is responsible for this effect, with some patients developing cross-tolerance to similar medication, posing a significant concern for medically intractable epilepsy

SourceBlackwell Publishing Ltd.·JournalEpilepsia·DateSep 6, 2006

NIH funds $2 million magnetic resonance system at Yale

The National Institutes of Health has awarded a $2 million grant to Yale University for the purchase of a 7-Tesla human magnetic resonance imaging system. This high-end instrumentation will facilitate ultra-high resolution studies in various medical fields, including diabetes and epilepsy.

SourceYale University·DateAug 18, 2006
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Epilepsy drug poses high risk for fetal death and birth defects

A recent study published in Neurology found that the epilepsy drug valproate poses a significantly higher risk of fetal death and birth defects than other commonly used epilepsy drugs. The study, which examined 333 pairs of mother and child, showed that over 20% of pregnancies exposed to valproate resulted in death or birth defects.

SourceAmerican Academy of Neurology·JournalNeurology·DateAug 7, 2006

UCLA develops unique nerve-stimulation epilepsy treatment

Researchers at UCLA develop trigeminal nerve stimulation (TNS) as a new alternative for controlling seizures in individuals who are resistant to medication or ineligible for surgery. The device uses a brain pacemaker to stimulate the trigeminal nerve, offering a potential advantage over vagus nerve stimulation.

SourceUniversity of California - Los Angeles·JournalEpilepsia·DateJul 25, 2006
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Cell phone emissions excite the brain cortex

Researchers in Italy found that exposure to cell phone EMFs can cause changes in the motor cortex of the brain. The effects were transient and reversible, but further studies are needed to understand the potential risks and benefits. The study has significant implications for individuals with conditions involving cortical excitability.

SourceWiley·JournalAnnals of Neurology·DateJun 26, 2006

UCI epilepsy researcher receives nation's top neuroscience prize

Dr. Tallie Z. Baram, a renowned UCI researcher, has been honored with the nation's top neuroscience prize for her pioneering work on childhood febrile seizures and their link to adult epilepsy. Her research has defined molecular changes in brain cells caused by early-life febrile seizures.

SourceUniversity of California - Irvine·DateJun 20, 2006

Protein's potential as a regulator of brain activity discovered

Scientists have discovered that agrin controls nerve cell excitability by regulating sodium pump activity in the brain, potentially leading to new treatments for epilepsy. Agrin also regulates potassium levels in heart tissue, raising the possibility of its use in treating congestive heart failure.

SourceUniversity of California - Irvine·JournalCell·DateApr 20, 2006
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Researchers identify new childhood-onset epilepsy disorder and its genetic cause

A new childhood-onset epilepsy disorder, cortical dysplasia-focal epilepsy syndrome (CDFE), has been identified in a group of Old Order Amish children. The disorder is caused by a genetic mutation in the CASPR2 protein, which plays a crucial role in maintaining physical contacts between neurons and neighboring glial cells.

SourceThe Translational Genomics Research Institute·JournalNew England Journal of Medicine·DateMar 29, 2006

Molecular mechanism may explain how fevers spark seizures

A study published in The Journal of Neuroscience found that high temperatures can reduce the number of GABA-A receptors on nerve cells' surfaces, making them more susceptible to seizures. This discovery may lead to new approaches for preventing recurrent febrile seizures in vulnerable children.

SourceVanderbilt University Medical Center·DateMar 10, 2006

MRI offers new hope for severe epilepsy sufferers

Researchers at McGill University have developed advanced MRI methods to improve detection of brain lesions in epilepsy patients. These new techniques reduce complexity and cost of pre-surgical evaluation, paving the way for more surgical treatment options.

SourceCanadian Institutes of Health Research·JournalEpilepsia·DateFeb 20, 2006
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Flexible drug dosing produces less side-effects in people with epilepsy

The study found that flexible drug dosing permitted patients to remain on the medication longer due to fewer side-effects, while also showing a significant clinical advantage in treating patients with epilepsy. This approach balances efficacy and tolerability, providing more realistic data on antiepileptic drugs.

SourceBlackwell Publishing Ltd.·JournalEpilepsia·DateDec 27, 2005

Brain research wins $1 million

Dr Anthony Hannan from the Howard Florey Institute has won a $1 million Pfizer Australia Research Fellowship to study environmental factors that delay degenerative brain diseases. His recent work showed that mental and physical exercise can slow down HD progression in mice, challenging genetic determinism.

SourceResearch Australia·DateDec 20, 2005

Depression and anxiety improve after epilepsy surgery

A study published in Neurology found that depression and anxiety disorders decreased by over 50% two years after epilepsy surgery. Participants who underwent successful surgery without seizures were more likely to be free from depression and anxiety.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalNeurology·DateDec 12, 2005

Depression and anxiety improve after epilepsy surgery

A recent study published in Neurology found that epilepsy surgery significantly improves mental health outcomes for patients. After the surgery, 9% of participants met the criteria for depression, compared to 22% before surgery. The study suggests removing dysfunctional brain areas may be critical to improving mental well-being.

SourceAmerican Academy of Neurology·JournalNeurology·DateDec 12, 2005

Dr. Tallie Z. Baram wins nation's top epilepsy research award

Dr. Tallie Z. Baram has been awarded the Epilepsy Research Recognition Award for her pioneering research on childhood febrile seizures and their potential link to adult epilepsy. Her work aims to develop new treatments that can calm childhood seizures without harming adults.

SourceUniversity of California - Irvine·DateDec 5, 2005
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Modified Atkins diet effectively treats childhood seizures

A study of 20 children with epilepsy found that 13 had a greater than 50 percent improvement and four were seizure-free after six months on the modified Atkins diet. The diet, which mimics ketosis, was better tolerated by children and easier to follow than the ketogenic diet.

SourceJohns Hopkins Medicine·DateDec 5, 2005

American Academy of Neurology elaborates expert witness guidelines

The American Academy of Neurology has updated its expert witness guidelines to promote competent, truthful, and evidence-based testimony. Physicians should be fully trained in their specialty or subject matter and conduct their testimony accurately and impartially.

SourceAmerican Academy of Neurology·JournalNeurology·DateNov 23, 2005
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Medicare elimination of essential drugs will affect elderly

The Medicare elimination of essential drugs will have a significant impact on 24% of elderly recipients, who will lose coverage for essential medications like benzodiazepines. This could lead to withdrawal reactions, emergency department visits, and hospital admissions.

SourceHarvard Medical School·JournalPsychiatric Services·DateOct 14, 2005

The Epilepsy Foundation issues Call to Action

The Epilepsy Foundation calls on women of childbearing age to assess their medication treatment for risk of birth defects caused by anticonvulsants. The organization provides guidance and resources to empower women to make informed decisions about their health.

SourceEpilepsy Foundation·DateOct 4, 2005

New battery technology helps stimulate nerves

Researchers at the University of Wisconsin-Madison have developed a new lithium battery technology that can make batteries smaller, last longer, and accept external charging without surgery. This breakthrough technology uses organosilicon compounds to improve battery lifespan, enabling implantable devices such as pacemakers and microst...

SourceUniversity of Wisconsin-Madison·DateOct 3, 2005

Advances in brain imaging for epilepsy

Researchers have found that a marker for serotonin systems can identify epilepsy-generating brain areas, even in patients with normal MRI scans. This breakthrough has the potential to reduce the need for invasive EEG studies and improve surgical outcomes for patients with uncontrolled seizures.

SourceAmerican Neurological Association·DateSep 21, 2005
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.